Alembic Pharma dips 5% on disappointing September quarter results
.jpg)
Shares of Alembic Pharmaceuticals dipped 5 per cent to Rs 757 on the BSE in the intra-day trade on Thursday after the company's consolidated profit declined 49 per cent year on year (YoY) at Rs 169 crore in September quarter (Q2FY22), due to lower revenue. The pharmaceutical company had posted profit of Rs 333 crore in the year-ago quarter.
At 10:45 am, the stock was trading 3.4 per cent lower at Rs 766.20, as compared to a 0.87 per cent decline in the S&P BSE Sensex. It had hit a 52-week low of Rs 720.80 on August 23, 2020.
In Q2FY22, the companys total revenue was down 11 per cent to Rs 1,292 crore from Rs 1,457 crore in Q2FY21. The US revenue declined 40 per cent to Rs 348 crore on YoY basis. However, India business grew 23 per cent to Rs 509 crore over the previous year quarter. Consolidated earnings before interest, tax, depreciation and amortization (ebitda), post R&D, contracted 21 per cent from 31 per cent.
The management believes the current US sales figures ($47 million per quarter) are the new base, and these are expected to improve hereafter, led by new launches.
"Alembic Pharmas subdued performance in US/API was offset by a better-than-expected show in the Domestic Formulation (DF) segment. The YoY declining trend in the US business has reached a trough with the limited impact of price erosion and an increased pace of launches going forward," Motilal Oswal Financial Services said.
The brokerage firm has lowered its FY22E/FY23E EPS estimate by 7.5 per cent/5.8 per cent, factoring in a delay in successful compliance at injectables sites, gradual revival in US sales, and higher RM/logistics costs.
Meanwhile, in exchange filing Alembic Pharma said that the United States Food and Drug Administration (USFDA) recently inspected the company’s injectable facility (F-3) site and issued Form 483 with 10 observations. "None of the observations are related to data integrity and management believes that they are addressable. The Company is preparing the response to the observations, which will be submitted to the USFDA," the company said.
Other Latest News
.webp)
Nearly nine years ago, Paytm founder and CEO Vijay Shekhar Sharma had remarked, "We are as Indian as Maruti," in an interview with PTI, responding to queries about the company's ownership structure at that time. That statement, once seen as symbolic, now reflects the reality, one where Paytm stands as a truly Indian company, both in spirit and shareholding.
.webp)
Congress MP Rahul Gandhi was granted bail on Wednesday by the MP-MLA court in Jharkhand's Chaibasa in a defamation case. The case was related to his alleged remarks against Union Home Minister Amit Shah during a political rally held in 2018.
“Rahul Gandhi ji appeared before the court as per the direction from the Jharkhand High Court. He had sought bail, which was granted. We will now take the process ahead,” said the Congress MP’s counsel.
.webp)
US President Donald Trump on Tuesday announced he would raise tariffs on Indian imports “very substantially” within the next 24 hours, citing New Delhi’s ongoing imports of Russian oil.
“They're fueling the war machine, and if they're going to do that, then I'm not going to be happy,” Trump told CNBC in an interview. He also criticised India’s existing tariff structure, calling it the primary point of contention.
.webp)
The Congress on Wednesday said the Opposition's demand for a discussion on the "votebandi" by the Election Commission is "non-negotiable" in both Houses of Parliament.
There has been a logjam in Parliament over the Special Intensive Revision of electoral rolls in Bihar, which the Opposition has alleged is being done to cut votes ahead of the state election.
.webp)
The Supreme Court strongly criticised an Allahabad High Court judge for permitting criminal proceedings in what was "clearly a civil case". The top court called his reasoning "shocking" and found his understanding of criminal law to be deeply flawed, Bar and Bench reported.
The apex court also directed the Chief Justice of the High Court to remove Justice Prashant Kumar from all criminal matters and ordered that such cases should not be assigned to him in the future.
.webp)
.webp)
.webp)
.webp)
.webp)
